We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA on Friday issued a draft guidance on its Voluntary Improvement Program (VIP), which uses third-party quality appraisals to help manufacturers improve their production and quality practices, signaling VIP’s transition from a pilot to a permanent program. Read More
The FDA issued a final guidance explaining its current policy on when agency staff may refuse to consider device companies’ applications for 510(k) clearance of a new product. Read More
A consumer of lidocaine patches sold by Target has filed a class-action lawsuit against the retailer, claiming that the devices don’t stick to the skin and aren’t strong enough. Read More
Developers of devices that are intended to improve glycemic control in patients with type 2 diabetes should conduct an early-stage feasibility and safety study to support additional trials that further hone in on feasibility, the FDA said in a final guidance. Read More
The FDA released a revised guidance clarifying when device sponsors that make certain low-risk product changes may not have to submit supplements for already approved premarket approvals (PMAs) or humanitarian device exemptions (HDEs) during the COVID-19 public health emergency. Read More
Belgium-based Ion Beam Applications (IBA) has acquired Modus Medical Devices, a Canadian manufacturer of “phantoms” used for quality assurance in radiation therapy. Read More
The FDA has issued a warning about counterfeit COVID-19 test kits that are being marketed in the U.S. — including fake Flowflex COVID-19 test kits and iHealth COVID-19 antigen rapid test kits. Read More
The FDA has clarified that it does not plan to regulate most software apps used in public health — such as the case-counting software programs that have been in use throughout the pandemic — as medical devices. Read More
The FDA is making significant organizational changes to the Center for Devices and Radiological Health (CDRH), which plays a lead role within the agency in how medical devices are evaluated or cleared for clinical investigations and marketing. Read More
Distinguishing between devices and drugs for regulatory purposes can be difficult in some cases, but the European Commission’s Medical Device Coordination Group (MDCG) has released a new guidance document that aims to help. Read More
Three device manufacturers reported positive study results for their products at the International Conference on Advanced Technologies and Treatments for Diabetes taking place this week in Barcelona, Spain. Read More